By proceeding, you agree to our Terms of Use and Privacy Policy.
Ying Buechler re-joined Ambrx in August 2018 as Vice President of Development. As the CMC leader, she is responsible for strategy and execution of protein therapeutics development and manufacturing.
Talks About #proteintherapeutics #biotech
Preferred Locations #NorthAmerica
3 years since we last brought the community together in-person in San Diego we are excited to once more unite 600+ ADC enthusiasts at the World’s Definitive Antibody-Drug Conjugate Event.
